<!DOCTYPE html>
<html id=6af3f8d930194d719bc003461386c565:97419190 data-origid=97419190 class="anndoc" data-anndoc-version="2.0" lang="" xml:lang="" xmlns="http://www.w3.org/1999/xhtml">
	<head>
		<meta charset="UTF-8"/>
		<meta name="generator" content="org.rostlab.relna"/>
		<title>6af3f8d930194d719bc003461386c565:97419190</title>
	</head>
	<body>
		<article>
			<section data-type="title">
				<h2 id="s1h1">Epstein-Barr virus binding to CD21 activates the initial viral promoter via NF-kappaB induction.</h2>
			</section>
			<section data-type="abstract">
				<div class="subsections">
					<h3 id="s2h1">Abstract</h3>
					<p id = "s2s1p1">Epstein-Barr virus (EBV), an oncogenic human herpesvirus, binds to and infects normal human B lymphocytes via CD21, the CR2 complement receptor. Studies of the mechanisms that enable EBV to infect nonactivated, noncycling B cells provide compelling evidence for a sequence of events in which EBV binding to CD21 on purified resting human B cells rapidly activates the NF-kappaB transcription factor, which, in turn, binds to and mediates transcriptional activation of Wp, the initial viral latent gene promoter. Thus, EBV binding to its cellular receptor on resting B cells triggers an NF-kappaB -dependent intracellular signaling pathway which is required for infection.</p>
				</div>
			</section>
		</article>
	</body>
</html>